Altogether, these findings illustrate that USP10 alleviates sepsis-induced AKI by regulating Sirt6-mediated Nrf2/ARE signaling pathway, proposing a novel target for the clinical treatment of AKI. Here, SIRT6 is linked to acute kidney injury.